(47 days)
Not Found
Not Found
No
The summary does not mention AI, ML, or any related terms, and the device description focuses on image capture capabilities.
No
The device is described as a camera used for diagnosis (captures photographs for optic disc glaucoma diagnosis), which indicates it is a diagnostic tool, not a therapeutic one.
Yes
The intended use explicitly states "suitable picture angle for stereoscopic optic disc glaucoma diagnosis", indicating its role in providing information for a medical diagnosis.
No
The device description explicitly states "Nidek 3-DX/3-DXF Stereo Disc/Fundus Cameras," indicating it is a hardware device (cameras) used to capture images.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Nidek 3-DX/3-DXF Stereo Disc/Fundus Cameras capture images of the eye's internal structures (disc and fundus). This is an in vivo process, meaning it's performed on a living organism, not on a sample taken from the body.
- Intended Use: The intended use is for capturing images suitable for stereoscopic optic disc glaucoma diagnosis and fluorescence angiography. This involves imaging the eye directly.
Therefore, the device falls under the category of medical imaging devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
Model 3-DX captures simultaneous stereo photographs of disc/ fundus area on a single frame - suitable picture angle for stereoscopic optic disc glaucoma diagnosis.
Model 3-DXF has an additional fluorescence angiography capability to 3-DX.
Product codes
86 HKI
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
disc/ fundus area
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.1120 Ophthalmic camera.
(a)
Identification. An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area.(b)
Classification. Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.
0
Image /page/0/Picture/2 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo features a stylized image of a human figure with three lines representing the head, body, and legs. The figure is positioned to the right of the text, which is arranged in a circular pattern around the left side of the logo. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV - 4 1997
Mr. Ken Kato Vice President Nidek, Inc. 47651 Westinghouse Drive Fremont, CA 94539
Re: K973533
Trade Name: Nidek 3- DX/3DXF Stereo Disc/Fundus Cameras Regulatory Class: II Product Code: 86 HKI Dated: September 17, 1997 Received: September18, 1997
Dear Mr. Kato:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III . (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
1
Page 2 - Mr. Kato
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
A. Ralph Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
| Page | of |
|---|---|
| CONSTITUTION CONSULTION CONTROLLERS OF CHART | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| THE CHANGE THE PERSONAL PROPERTY |
510(k) Number (if known): K9735333
Nidek 3-DX/3-DXF Stereo Disc/Fundus Cameras Device Name:
Indications For Use:
Model 3-DX captures simultaneous stereo photographs of disc/ fundus area on a single frame - suitable picture angle for stereoscopic optic disc glaucoma diagnosis.
Model 3-DXF has an additional fluorescence angiography capability to 3-DX.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Am Williams
(Division Sign-Off)
Division of Ophthalmic Devices
510(k) Number K973533
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
cK-20